PF-Atlas › Clinical Trials › NCT04467957
Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis
Initiation of CFTR Modulator · Phase 4
Registry ID
NCT04467957
Phase
Phase 4
Status
Active, not recruiting
Drug / intervention
Initiation of CFTR Modulator
Sponsor
Children's Hospital Medical Center, Cincinnati
Start
2020-11-15
About this trial
Initiation of CFTR Modulator is evaluated in NCT04467957, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Children's Hospital Medical Center, Cincinnati. Current status: Active, not recruiting.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04467957 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.